OpenAI & Eli Lilly and Company
5 shared events · Importance 4 · Last updated Jun 30, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
OpenAI: OpenAI>>> confidentially filed for a U.S. initial public offering, signaling a move towards public markets and potentially impacting the tech sector.
Eli Lilly and Company: Eli Lilly and Company>>> advanced after positive trial results for its next-generation obesity drug, retatrutide, which showed benefits beyond weight loss.
May 20, 2026 · 72 articles
Business
OpenAI: Filed for IPO; reportedly considering delaying IPO to next year.
Eli Lilly and Company: Eli Lilly's stock jumped after a committee of the European Medicines Agency recommended one of its medicines for approval, boosting its market performance.
Apr 20, 2026 · 344 articles
Domestic
OpenAI: The OpenAI Foundation is an anchor partner with RaiseMe, supporting programs aimed at helping workers adapt to an economy increasingly automated by AI.
Eli Lilly and Company: Eli Lilly is an employer involved in the RaiseMe project, contributing to the nonprofit's goal of adapting the workforce to an AI economy.
Jun 25, 2026 · 7 articles
Business
OpenAI: OpenAI is another AI company expected to go public this year, with its IPO performance being scrutinized in the wake of SpaceX's debut. SpaceX aims to outdo OpenAI in the AI market.
Eli Lilly and Company: Eli Lilly and Company is mentioned as one of the companies that SpaceX's valuation will surpass, emphasizing the magnitude of SpaceX's market entry.
Mar 09, 2018 · 538 articles
Domestic
Eli Lilly and Company: Eli Lilly and Company saw gains that helped offset drops in other sectors, contributing to the overall positive market performance.
Dec 11, 2025 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how OpenAI and Eli Lilly and Company interact across events, view sentiment trends, and discover connected entities.
Open Dashboard